Skip to main content
BEAM logo

BEAM · Beam Therapeutics Inc. · Analyst Estimates

Track BEAM — free
$24.49 +0.04 (+0.18%) At close · Oct 1
Market Cap
$2.53B
Shares
103.29M
Volume · Oct 1 1.7M Avg daily vol (3M) 1.99M

Analyst Estimates

Compare analyst forecasts for Beam Therapeutics Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 11:56 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.76217
-4.45352
-4.23843
—
-4.45352
-4.45288
-4.45352
-4.46869
— — — —
EPS
analysts
Publication date not stated
— — —
14
— — — —
5
5
4
4
Revenue
USD
Publication date not stated
0
48572180
95704000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-5.7189
-4.74137
-3.56
—
-4.74137
-4.7288
-4.74137
-4.74351
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
3
3
5
5
Revenue
USD
Publication date not stated
4000000
62748780
138302000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.27782
-1.16952
-1.05284
—
-1.16952
-1.1744
-1.16952
-1.18098
— — — —
EPS
analysts
Publication date not stated
— — —
13
— — — —
5
5
4
4
Revenue
USD
Publication date not stated
494900
9959580
31738000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.34364
-1.18693
-1.06
—
-1.18693
-1.197
-1.18693
-1.20492
— — — —
EPS
analysts
Publication date not stated
— — —
13
— — — —
6
6
3
3
Revenue
USD
Publication date not stated
500000
11571300
32221800
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —
Key facts CIK 1745999 CUSIP 07373V105 13F (30d) 7 filings 7 filers Visit website Investor relations